Moreover, our data indicate that AML blasts exploit RAS activated downstream signaling pathways (MEK-ERK1/2 and PI3K-AKT) to sustain primarily cell survival and proliferation. This evidence concerns the gene MAPK3 and acute myeloid leukemia.